Brian Yordy, Norifumi Iijima, Anita Huttner, David Leib, Akiko Iwasaki 

Slides:



Advertisements
Similar presentations
Volume 24, Issue 3, Pages (March 2006)
Advertisements

Volume 22, Issue 4, Pages e4 (October 2017)
Volume 26, Issue 3, Pages (March 2007)
Volume 18, Issue 6, Pages (December 2015)
The Interferon-Inducible MxB Protein Inhibits HIV-1 Infection
Volume 32, Issue 3, Pages (March 2010)
Volume 6, Issue 5, Pages (November 2009)
Volume 14, Issue 3, Pages (September 2013)
Volume 11, Issue 6, Pages (June 2012)
Volume 25, Issue 5, Pages (November 2006)
Prevention of Genital Herpes Simplex Virus Type 1 and 2 Disease in Mice Immunized with a gD-Expressing Dominant-Negative Recombinant HSV-1  Richard Brans,
DAI/ZBP1/DLM-1 Complexes with RIP3 to Mediate Virus-Induced Programmed Necrosis that Is Targeted by Murine Cytomegalovirus vIRA  Jason W. Upton, William J.
Volume 15, Issue 4, Pages (April 2014)
Volume 40, Issue 6, Pages (June 2014)
Volume 4, Issue 4, Pages (October 2008)
Volume 22, Issue 3, Pages e5 (September 2017)
Volume 1, Issue 1, Pages (March 2007)
Influenza Virus-Induced Glucocorticoids Compromise Innate Host Defense against a Secondary Bacterial Infection  Amanda M. Jamieson, Shuang Yu, Charles.
Volume 8, Issue 6, Pages (December 2010)
Volume 42, Issue 4, Pages (April 2015)
Volume 10, Issue 3, Pages (September 2011)
A Mouse Model of Zika Virus Pathogenesis
Mast Cells Play a Key Role in Host Defense against Herpes Simplex Virus Infection through TNF-α and IL-6 Production  Rui Aoki, Tatsuyoshi Kawamura, Fumi.
Volume 36, Issue 4, Pages (April 2012)
Volume 32, Issue 2, Pages (February 2010)
Alex M. Agelidis, Satvik R. Hadigal, Dinesh Jaishankar, Deepak Shukla 
Volume 2, Issue 6, Pages (December 2007)
Volume 19, Issue 2, Pages (February 2016)
Cell-to-Cell Transfer of M
Phospholipid Scramblase 1 Mediates Type I Interferon-Induced Protection against Staphylococcal α-Toxin  Miroslaw Lizak, Timur O. Yarovinsky  Cell Host.
Volume 22, Issue 1, Pages e7 (July 2017)
Tamar Hermesh, Bruno Moltedo, Thomas M. Moran, Carolina B. López 
Volume 21, Issue 6, Pages (November 2017)
T Cell-Produced Transforming Growth Factor-β1 Controls T Cell Tolerance and Regulates Th1- and Th17-Cell Differentiation  Ming O. Li, Yisong Y. Wan, Richard.
Volume 40, Issue 1, Pages (January 2014)
Volume 17, Issue 4, Pages (April 2015)
Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling
Incorporation of the B18R Gene of Vaccinia Virus Into an Oncolytic Herpes Simplex Virus Improves Antitumor Activity  Xinping Fu, Armando Rivera, Lihua.
Volume 7, Issue 5, Pages (May 2010)
C5a Negatively Regulates Toll-like Receptor 4-Induced Immune Responses
Volume 12, Issue 2, Pages (August 2012)
Volume 22, Issue 2, Pages (February 2005)
Volume 11, Issue 4, Pages (April 2012)
Volume 6, Issue 1, Pages (July 2009)
Volume 16, Issue 3, Pages (September 2014)
Cell Type-Specific Involvement of RIG-I in Antiviral Response
Volume 18, Issue 6, Pages (December 2015)
Volume 17, Issue 6, Pages (June 2015)
CD40, but Not CD40L, Is Required for the Optimal Priming of T Cells and Control of Aerosol M. tuberculosis Infection  Vanja Lazarevic, Amy J Myers, Charles.
Volume 166, Issue 5, Pages e4 (August 2016)
Volume 10, Issue 1, Pages (July 2011)
Melissa B. Uccellini, Adolfo García-Sastre  Cell Reports 
Urtzi Garaigorta, Francis V. Chisari  Cell Host & Microbe 
Volume 5, Issue 5, Pages (May 2009)
Cellular 5′-3′ mRNA Exonuclease Xrn1 Controls Double-Stranded RNA Accumulation and Anti-Viral Responses  Hannah M. Burgess, Ian Mohr  Cell Host & Microbe 
Volume 13, Issue 7, Pages (November 2015)
Cell-Intrinsic IL-27 and gp130 Cytokine Receptor Signaling Regulates Virus-Specific CD4+ T Cell Responses and Viral Control during Chronic Infection 
Volume 37, Issue 6, Pages (December 2012)
Volume 8, Issue 2, Pages (August 2010)
Targeted Cleavage of Signaling Proteins by Caspase 3 Inhibits T Cell Receptor Signaling in Anergic T Cells  Irene Puga, Anjana Rao, Fernando Macian  Immunity 
Volume 9, Issue 2, Pages (February 2011)
Volume 32, Issue 1, Pages (January 2010)
Volume 24, Issue 3, Pages (March 2006)
Volume 166, Issue 5, Pages e4 (August 2016)
PU.1 Expression Delineates Heterogeneity in Primary Th2 Cells
Volume 15, Issue 4, Pages (April 2014)
Volume 14, Issue 1, Pages (July 2013)
Volume 31, Issue 5, Pages (September 2008)
Volume 20, Issue 2, Pages (August 2016)
Volume 11, Issue 6, Pages (June 2012)
Presentation transcript:

A Neuron-Specific Role for Autophagy in Antiviral Defense against Herpes Simplex Virus  Brian Yordy, Norifumi Iijima, Anita Huttner, David Leib, Akiko Iwasaki  Cell Host & Microbe  Volume 12, Issue 3, Pages 334-345 (September 2012) DOI: 10.1016/j.chom.2012.07.013 Copyright © 2012 Elsevier Inc. Terms and Conditions

Cell Host & Microbe 2012 12, 334-345DOI: (10.1016/j.chom.2012.07.013) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 1 Neurons Are Impaired in Their Capacity to Respond to Viral Stimulation and Induce Type I IFNs (A and B) Mouse embryonic fibroblasts (MEFs) and neurons were infected with HSV1-GFP at MOIs of 0.1, 1.0, and 10.0. RNA was isolated from all cells at 0, 12, 24, and 54 hr after infection. Relative fold increases in IFN-α4 (A) and IFN-β (B) production were determined by quantitative RT-PCR of isolated RNA relative to the housekeeping gene hprt. (C and D) MEFs, keratinocytes, and neurons were transfected with Poly I:C (1.0 μg/ml). RNA was isolated from all cells at the time points indicated, and fold increases of IFN-α4 (C) and IFN-β (D) relative to hprt were determined by RT-qPCR. Data are representative of three independent experiments. See also Figure S1. Cell Host & Microbe 2012 12, 334-345DOI: (10.1016/j.chom.2012.07.013) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 2 Neurons Have Impaired Type I IFN-Dependent Anti-HSV-1 Protection Primary keratinocytes, MEFs, and neurons were pretreated for 18 hr with the indicated amount of IFN-β. After pretreatment, all cells were infected with 0.5 MOI of HSV1-GFP. At the time points indicated, cells were isolated and analyzed for GFP expression by flow cytometry. Data are shown as number of infected cells (GFP+) per 10,000 cell events for MEFs (A), keratinocytes (B), and neurons (C). Data are representative of four independent experiments. See also Figure S2. Cell Host & Microbe 2012 12, 334-345DOI: (10.1016/j.chom.2012.07.013) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 3 Type I Interferon Primes Mitotic Cells, but Not Neurons, for Cell Death (A) MEFs, and neurons were pretreated for 18 hr with the indicated amount of IFN-β. All cells were then transfected with Poly I:C (1.0 μg/ml) for 1 hr. At the time points indicated, MEFs and neurons were isolated, stained with trypan blue, and counted by hematocytometer (top). MEFs and neurons were isolated, stained with Annexin V and 7-AAD, and analyzed by flow cytometry (bottom). Data are representative of three independent experiments. (B) MEFs and neurons were treated with staurosporine and isolated, stained with trypan blue, and counted by hematocytometer at the time points indicated. Error bars represent SEM. See also Figure S3. Cell Host & Microbe 2012 12, 334-345DOI: (10.1016/j.chom.2012.07.013) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 4 Viral Inhibition of Autophagy in an Infected, Nonepithelial Cell Type Is Required for HSV-1-Induced Disease (A–D) Keratinocytes and total liver were isolated from Atg5flox.flox Krt14cre+ (KO) and Atg5flox.flox Krt14cre– (WT) mice. Atg5 mRNA expression relative to levels in KO is shown for keratinocytes (A) and liver (C). Western blot analysis of LC3-I and LC3-II from isolated keratinocytes (B) and total liver (D) is shown. Loading control (β-actin) for each sample is shown below. n > 2 for all genotypes, and data are representative of two independent experiments. (E–H) Depo-provera-treated Atg5 flox/flox × Krt14-cre Tg (KC-Atg5 KO) and Atg5 flox/flox Krt14cre(–) (WT) littermates were intravaginally infected with 5,000 pfu of either HSV-1 bbd or the rescue virus bbdR. Vaginal washes were collected daily and viral titers were measured (E). Mice were weighed (F), clinically scored (G), and monitored for survival (H) every 24 hr after infection. Error bars represent SEM of n ≥ 12 mice per group. ∗∗p ≤ .001, ∗∗∗p ≤ .0005 mortality of bbdR-infected mice relative to bbd infection. Data are pooled from three independent experiments. See also Figure S4. Cell Host & Microbe 2012 12, 334-345DOI: (10.1016/j.chom.2012.07.013) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 5 Neuroattenuation of bbd Is Independent of T Cell Responses (A–C) Depo-provera-treated WT C57BL/6 mice were intravaginally infected with 20,000 pfu of HSV-1 bbd or the rescue mutant bbdR, and were analyzed on days 6 and 8 after infection. Total number of lymphocytes (A), and CD4+ T cells (B) from the iliac and lingual draining lymph nodes is depicted. Isolated CD4+ T cells were cocultured with naive splenocytes in the presence of heat-inactivated HSV-1 (C). IFN-γ secretion from CD4+ T cells was measured by ELISA. (D–G) Cd4−/− (dotted line), Cd8−/− (dotted line), and WT control C57BL/6 mice were intravaginally infected with 2,000 pfu of the indicated strain of HSV-1. Vaginal washes of Cd4−/− (D) and Cd8−/− (F) mice were collected daily and viral titers were measured in Vero cells. Cd4−/− (E) and Cd8−/− (G) mice were monitored for survival every 24 hr after infection. Error bars represent SEM of n ≥ 5 mice per group. Data are pooled from four (A–C) or three (D–F) independent experiments. See also Figure S5. Cell Host & Microbe 2012 12, 334-345DOI: (10.1016/j.chom.2012.07.013) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 6 Autophagy Is Required to Restrict Neuronal HSV-1 Replication Depo-provera treated wild-type C57BL/6 mice were infected with 2 × 104 pfu of the indicated strain of HSV-1. Dorsal root ganglia, spinal cord, and brainstem were isolated at the time points indicated and homogenized. Viral titers were measured in Vero cells (A–C), and genome copy of isolated DNA was determined by qPCR (D–F). Error bars represent SEM (A–C) of n > 5 and n > 4 (D–F). Gray dotted lines indicate the limit of detection. Data are pooled from three independent experiments. ∗p < 0.05; ns, not significant. See also Figure S6. Cell Host & Microbe 2012 12, 334-345DOI: (10.1016/j.chom.2012.07.013) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 7 Autophagy and Type I IFNs Restrict HSV-1 Replication in Neurons in Parallel Primary neurons were isolated from Atg5 flox/flox × Nestin-cre Tg (Neuron Atg5 KO) and Atg5 flox/flox Nestin-cre(–) (WT) littermates. Neurons were infected at the indicated MOI with either bbd or bbdR HSV-1, at MOI of 0.01 (A), or at MOI of 0.1 with or without treatment with 1,000 U/ml of IFN-β 18 hr prior to infection (D). (A and D) Supernatants were collected at points indicated and viral titers were measured. (B and C) RNA isolated from neurons treated with 1,000 U/ml IFN-β alone (B) or followed by HSV-1 infection for additional 48 hr was used to measure expression of indicated ISG by RT-qPCR. Error bars represent SEM and data are representative of two to four independent experiments. Gray dotted lines indicate limit of detection. See also Figure S7. Cell Host & Microbe 2012 12, 334-345DOI: (10.1016/j.chom.2012.07.013) Copyright © 2012 Elsevier Inc. Terms and Conditions